Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2010
12/15/2010CN101918369A N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (HCV) inhibitors
12/15/2010CN101918365A Inhibitors of human immunodeficiency virus replication
12/15/2010CN101918362A Pyridine derivatives
12/15/2010CN101918360A Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity
12/15/2010CN101914095A 2-chloropyridine derivative, preparation method and application thereof to preparation of medicines resistant to liver cancer
12/15/2010CN101914094A 1,3,4-oxadiazole derivative, preparation method and application thereof in preparing antitumor drug
12/15/2010CN101914093A Reactive heterocycle-substituted 7-hydroxycoumarins and their conjugates
12/15/2010CN101235131B Method for preparing benzoxazine intermediate containing propargyl ether and resin thereof
12/15/2010CN101171238B (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-HT receptor
12/14/2010US7851473 fatty acid amide hydrolase inhibitors such as N-(2-Chlorophenyl)-4-(3-phenyl-1,2,4-thiadiazol-5-yl)piperazine-1-carboxamide, used for the prophylaxis of brain, psychological or sleep disorders, as neuroprotectants, analgesics, antidepressants or anxiolytic agents
12/14/2010US7851472 Cyclopropanecarboxylic acid {4-[3-(4-methoxy-phenyl)-[1,2,4]triazolo[3,4-a]phthalazin-6-ylamino]-phenyl}-amide; phosphodiesterase inhibitors; neoangiogenesis or inflammatory disease
12/14/2010US7851471 Compounds I
12/14/2010US7851468 Substituted pyrazolo[3,4-d]pyrimidines
12/14/2010CA2535199C Amide derivative
12/14/2010CA2430909C Inhibitors of papilloma virus
12/14/2010CA2400124C Tnf-.alpha. inhibitors
12/14/2010CA2159546C Cycloalkano-indole and -azaindole derivatives
12/09/2010WO2010141809A1 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase
12/09/2010WO2010141768A2 Polycyclic antagonists of lysophosphatidic acid receptors
12/09/2010WO2010141680A2 Hedgehog pathway antagonists and methods of use
12/09/2010WO2010141424A1 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/09/2010WO2010141360A1 Biaryl benzotriazole derivatives
12/09/2010WO2010140802A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
12/09/2010WO2010140156A2 Novel polymorphs of raltegravir potassium
12/09/2010WO2010140132A1 Process for the preparation of crystalline aprepitant having form i content
12/09/2010WO2010139966A1 Azole derivatives as wtn pathway inhibitors
12/09/2010WO2010139758A1 Novel derivatives of aryl-{4-halogeno-4-[aminomethyl]-piperidin-1-yl}-methanone, their method of preparation and their use as medicinal products
12/09/2010WO2010139673A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/09/2010WO2010115836A4 Substituted piperidines as ccr3 antagonists
12/09/2010WO2010058423A3 Novel antimicrobials
12/09/2010WO2009130469A8 Dna-pk inhibitors
12/09/2010WO2009127944A8 Ether benzylidene piperidine aryl carboxamide compounds useful as faah inhibitors
12/09/2010US20100311965 2-aminoquinazoline derivative
12/09/2010US20100311797 Novel Compounds
12/09/2010US20100311778 Chromane derivatives as trpv3 modulators
12/09/2010US20100311754 1,4-Disubstituted Naphthalenes as Inhibitors of P38 Map Kinase
12/09/2010US20100311753 C5aR ANTAGONISTS
12/09/2010US20100311752 Substituted pyridazine derivatives
12/09/2010US20100311750 Organic compounds
12/09/2010US20100311749 4-benzoyl-1-substituted-piperazin-2-one derivatives as p2x7 modulators
12/09/2010US20100311747 Dicycloazaalkane derivates, preparation processes and medical uses thereof
12/09/2010US20100311745 1,3-dihydroisoindole derivatives
12/09/2010US20100311744 Novel 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 and p40
12/09/2010US20100311739 Naphthalene Diimide Compounds
12/09/2010US20100311736 Pyridosulfonamide derivatives as p13 kinase inhibitors
12/09/2010US20100311735 Inhibitors of human immunodeficiency virus replication
12/09/2010US20100311730 Pyrazin-2-yl-pyridin-2-yl-amine and pyrazin-2-yl-pyrimidin-4-yl-amine Compounds and Their Use
12/09/2010US20100311727 Therapeutic amine-arylsulfonamide conjugate compounds
12/09/2010US20100311721 Compounds
12/09/2010US20100311715 Alpha carbolines and uses thereof
12/09/2010US20100310500 Alkanoylamino benzamide aniline hdac inhibitor compounds
12/09/2010CA2764339A1 Azole derivatives as wtn pathway inhibitors
12/08/2010EP2258701A1 2-morpholino-4-pyrimidone compound
12/08/2010EP2258700A1 Cycloalkylamino acid derivatives and pharmaceutical compositions thereof
12/08/2010EP2258694A1 Amines as histamine-3 receptor ligands and their therapeutic applications
12/08/2010EP2258690A1 Tricyclic amines as intermediates in the synthesis of fungicidal carboxamide derivatives
12/08/2010EP2258366A2 Quinoline derivatives and quinazoline derivatives capable of inhibiting autophosphorylation of hepatocyte growth factor receptors, and pharmaceutical composition comprising the same
12/08/2010EP2257543A1 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof 177
12/08/2010EP2257541A1 Modulators for amyloid beta
12/08/2010EP2257297A1 Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor
12/08/2010EP2257167A1 2-aminoimidazole beta-secretase inhibitors for the treatment of alzheimer's disease
12/08/2010EP1858857B1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists
12/08/2010EP1857108B1 Preventive or therapeutic agent for herpesvirus-related disease
12/08/2010EP1628685B1 Antiviral phosphonate analogs
12/08/2010CN1821243B Substituted pyridine M1 receptor excitomotor, its preparing process and its use
12/08/2010CN1671696B Kinase inhibitors
12/08/2010CN101910161A Insecticidal compounds
12/08/2010CN101910160A Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1
12/08/2010CN101910159A Process for production of heterocycle-substituted pyridine derivative
12/08/2010CN101910158A Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders
12/08/2010CN101910155A Biphenyl derivatives as modulators of the histamine-H3 receptor useful for the treatment of disorders related thereto
12/08/2010CN101910152A 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors
12/08/2010CN101910150A 4-benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
12/08/2010CN101910145A Heterocyclic antiviral compounds
12/08/2010CN101910142A Modulators for amyloid beta
12/08/2010CN101910133A Heterocycle phenyl amide T-type calcium channel antagonists
12/08/2010CN101910129A Synthesis of quaternary salt compounds
12/08/2010CN101906071A Dioxane-2-alkyl carbamates derivatives
12/08/2010CN101307050B Oxazole substituted dihydro pyrazol multi-heterocyclic ring derivates, preparation method and uses thereof
12/08/2010CN101087777B Pyrrolidinium derivatives as M3 muscarinic receptors
12/07/2010USRE41990 epothilone derivatives used for the treatment of cancer and cancers which have developed a multidrug-resistant phenotype; anticarcinogenic agents
12/07/2010US7847101 such as (4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-[2-(1H-imidazol-4-yl)-ethyl]-amine, used in the treatment of disorders associated with hyperproliferation and tissue remodelling or repair, inflammation, cell migration and invasion, and renal diseases, or as protein kinase inhibitors
12/07/2010US7847100 enzyme ihibitors such as 3-{5-[(1R)-1-amino-1-methyl-2-phenylethyl]-1,3,4-oxadiazol-2-yl}-N-[(1R)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]benzamide, used for treating neurodegenerative diseases
12/07/2010US7847095 Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1.,2,4-triazol-3-one
12/07/2010US7846959 Raf modulators and methods of use
12/07/2010US7846945 2-[4-Chloro-3-(4-hydroxy-benzyl)-phenyl]-6-methoxy-tetrahydro-pyran-3,4,5-triol; 2-[4-Chloro-3-(4-ethoxy-benzyl)-phenyl]-3,4,5-trihydroxy-piperidine-1-carboxylic acid methyl ester; (2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-methoxytetrahydro-2H-thiopyran-3,4,5-triol; antidibetic, antiobesity agents
12/07/2010US7846930 2-Methyl-4-(4-methylsulfanyl-phenyl)-7-(3-piperidin-1-ylmethyl-phenoxy)-1,2,3,4-tetrahydro-isoquinoline, used for the treatment of cognitive disorders, sleep disorders and psychiatric disorders
12/07/2010US7846929 Using 1-(4-((2-(aminopyrimidin-5-yl)-4-morpholinothieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-(methylsulfonyl)ethanone; lipid kinase inhibitor; anticancer agents ; antiinflammatory agents; antidiabetic agents
12/07/2010US7846928 Interfere with Tie2 signalling; Tie (tyrosine kinase with immunoglobulin and epidermal growth factor homology domain) receptor tyrosine kinase; antitumor, antimetastasis agents; for example, 1-[4-(6-tert-Butyl-1H-pyrazolo[3,4-b]pyridin-4-yl)-phenyl]-3-(3-ethyl-phenyl)-urea
12/07/2010US7846927 N,N′-diphenylurea derivatives suitable as kinase inhibitors
12/07/2010US7846926 podophyllotoxin derivatives such as (2-{3-[4-(3-aminopropylamino)-butylamino]-propylamino}-N-[9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5,6,8,8a,9-hexahydrofuro[3',4':6,7]naptho[2,3-d][1,3]dioxol-5-yl]-acetamide, used as anticarcinogenic agents
12/07/2010US7846924 Cyanopyrroles
12/07/2010US7846922 1-(isopropyl)-4-{[4-(tetrahydro-2H-pyran4-yloxy)phenyl]carbonyl}hexahydro-1H-1,4-diazepine, used in the treatment of nervous system and psychological disorders such as Alzheimer's disease or as cognition activators
12/07/2010CA2588662C New 3-phenylpropionic acid derivatives for the treatment of diabetes
12/07/2010CA2374995C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
12/02/2010WO2010138649A1 Oxazolidinone containing dimer compounds, compositions and methods to make and use
12/02/2010WO2010138578A1 Pyrimidine inhibitors of kinase activity
12/02/2010WO2010138490A1 Benzoxazepines as inhibitors of mtor and methods of their use and manufacture
12/02/2010WO2010138488A1 Hepatitis c virus inhibitors
12/02/2010WO2010138487A1 BENZOXAZEPINES AS INHIBITORS OF PI3K/m TOR AND METHODS OF THEIR USE AND MANUFACTURE
1 ... 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 ... 647